WUXI NEWS

Big Data and Genomics Meet the Cloud: the First Unified Global Platform for Precision Medicine
IND Application for WuXi MedImmune’s Monoclonal Antibody Accepted for Review by CFDA

IND Application for WuXi MedImmune’s Monoclonal Antibody Accepted for Review by CFDA

IND application for WuXi MedImmune’s novel monoclonal antibody for rheumatoid arthritis has been accepted.  Read more.

deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide

deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide

Congratulations to the scientists at deCODE genetics on their publication. Read more.

Nobel Prize Laureate Professor Barry Sharpless Visits WuXi

Nobel Prize Laureate Professor Barry Sharpless Visits WuXi

Professor Barry Sharpless, a Nobel Prize Laureate and Professor at The Scripps Research Institute, visited our Shanghai headquarters.  Read more.

---

FDA APPROVALS AND DESIGNATIONS

---
---

Thank you for your support in helping WuXi reach where we are today. We will continue with our goal - to serve you better with our integrated technology and capability platform.
 Office of Corporate Communications, WuXi AppTec

Web: www.wuxiapptec.com | Email: communications@wuxiapptec.com